Rhenman & Partners Asset Management Ab Deciphera Pharmaceuticals, Inc. Transaction History

Rhenman & Partners Asset Management Ab

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $412,200 - $666,600	-60,000 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$51.77 - $66.18 $3.11 Million - $3.97 Million	60,000 New	60,000 $3.42 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.